Evidence map›Paper›PMID 42039835›Full record

ArticleFrontiers in microbiology2026

Development of a recombinase polymerase amplification-based chromogenic assay for rapid detection of

Chang Liu, Han Ren, Yi Li, Boyang Li, Qiuyu Wei, Xiangdong Xu, Huan Ren

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chang LiuSchool of Public Health, Hebei Medical University, Shijiazhuang, China.
Han RenXinle Traditional Chinese Medicine Hospital, Shijiazhuang, China.
Yi LiHebei Medical University, Shijiazhuang, China.
Boyang LiXinle Traditional Chinese Medicine Hospital, Shijiazhuang, China.
Qiuyu WeiSchool of Public Health, Hebei Medical University, Shijiazhuang, China.
Xiangdong XuSchool of Public Health, Hebei Medical University, Shijiazhuang, China.
Huan RenSchool of Public Health, Hebei Medical University, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: A label-free, equipment-free detection method was developed by integrating recombinase polymerase amplification (RPA) with G-quadruplex (G4)/hemin DNAzyme catalysis. Tandem cytosine repeat-modified primers targeting the Results: The entire detection process was completed within 1 hour, with a limit of detection (LOD) as low as 12 CFU/ml. Specificity testing confirmed no cross-reactivity with non-target bacteria, including Discussion: This accurate, portable, and user-friendly detection platform offers promising applications for

Indexed as

DNAzymeG-quadruplexrapid detectionrecombinase polymerase amplificationSalmonella spp.

Identifiers

PMID42039835
PMCPMC13106402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.